Biotech companies by dividend yield
Dividends paid over the last twelve months as a share of today's price.
Amgen leads the 20 biotech companies ranked by dividend yield, at 2.17%, ahead of Gilead Sciences (1.91%) and Bio-Techne (0.33%). Figures as of 18 Nov 2026, 17:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Amgen2.17%
- Median
- 0.00%
- Combined market value
- NOK 8.17T
- Countries
- 5
- Not ranked
- 4no dividend yield on file
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Dividend yield ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | 2.17% | NOK 2.34T | NOK 4,328.15 | 2.50% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | 1.91% | NOK 2.04T | NOK 1,641.11 | 0.57% down | 33% up | ||
| 3 | Bio-TechneTECH · Health Care | 0.33% | NOK 110.8B | NOK 705.56 | 0.21% up | 26% up | ||
| 4 | ModernaMRNA · Health Care | 0.00% | NOK 795.7B | NOK 1,966.46 | 1.91% down | 755% up | ||
| 5 | BiogenBIIB · Health Care | 0.00% | NOK 361.2B | NOK 2,443.27 | 0.49% up | 49% up | ||
| 6 | Revolution MedicinesRVMD · Health Care | 0.00% | NOK 335.5B | NOK 1,551.25 | 1.64% down | 131% up | ||
| 7 | ExelixisEXEL · Health Care | 0.00% | NOK 163.6B | NOK 670.66 | 0.99% up | 63% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | 0.00% | NOK 159.5B | NOK 1,576.02 | 2.02% down | 20% up | ||
| 9 | RepligenRGEN · Health Care | 0.00% | NOK 106.9B | NOK 1,672.47 | 6.38% up | 5% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | 0.00% | NOK 106.9B | NOK 937.54 | 0.77% up | 37% up | ||
| 11 | Kymera TherapeuticsKYMR · Health Care | 0.00% | NOK 101.2B | NOK 1,185.53 | 0.63% up | 87% up | ||
| 12 | VaxcytePCVX · Health Care | 0.00% | NOK 90.6B | NOK 572.40 | 0.60% down | 22% up | ||
| 13 | Krystal BiotechKRYS · Health Care | 0.00% | NOK 90.2B | NOK 3,043.55 | 5.16% up | 46% up | ||
| 14 | Twist BioscienceTWST · Health Care | 0.00% | NOK 77.8B | NOK 1,141.80 | 5.16% up | 340% up | ||
| 15 | CG OncologyCGON · Health Care | 0.00% | NOK 70.7B | NOK 791.11 | 3.38% up | 85% up | ||
| 16 | ImmunityBioIBRX · Health Care | 0.00% | NOK 69.4B | NOK 65.24 | 7.51% up | 193% up | ||
| 17 | ImmunovantIMVT · Health Care | 0.00% | NOK 67.5B | NOK 326.02 | 1.26% up | 43% up | ||
| 18 | Kodiak SciencesKOD · Health Care | 0.00% | NOK 61.9B | NOK 946.95 | 0.91% up | 396% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | 0.00% | NOK 56B | NOK 458.93 | 5.01% up | 14% up | ||
| 20 | Adaptive BiotechnologiesADPT · Health Care | 0.00% | NOK 45B | NOK 277.94 | 0.63% up | 88% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6944 NOK). 4 companies have no dividend yield on file and are not ranked here.
Questions and answers
Which biotech companies rank first by dividend yield?
Amgen (2.17%), Gilead Sciences (1.91%) and Bio-Techne (0.33%) are the top three of the 20 biotech companies ranked by dividend yield as of 18 Nov 2026, 17:47 UTC.
How many biotech companies are in this ranking?
20 are ranked by dividend yield. 4 more have no dividend yield on file and are left out rather than ranked at zero.
What are these biotech companies worth together?
The 20 biotech companies ranked by dividend yield have a combined market value of NOK 8.17T as of 18 Nov 2026, 17:47 UTC.
What does ranking by dividend yield measure?
Dividends paid over the last twelve months as a share of today's price.
Learn how this ranking works
All markets guides →- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Biotech companies by dividend yield”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=dividend-yield
Underlying data: Yahoo Finance; SEC EDGAR.